Skip to content

Drug interactions

Bromocriptine + Larotrectinib

Severity: Minor

Bromocriptine and Larotrectinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Larotrectinib is a CYP3A4 substrate with limited inhibitory activity, so a clinically meaningful effect on bromocriptine is uncertain. Any increase in bromocriptine exposure is expected to be small.

What this interaction means in plain words

Bromocriptine and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Bromocriptine belongs to Central Nervous System; Larotrectinib belongs to Oncology.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition by larotrectinib; not well established.

What to do

No routine adjustment is needed. Watch for dopaminergic adverse effects such as nausea or hypotension.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bromocriptine and Larotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bromocriptine with Larotrectinib?

MediHelp rates the interaction as minor. Bromocriptine and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Larotrectinib is a CYP3A4 substrate with limited inhibitory activity, so a clinically meaningful effect on bromocriptine is uncertain. Any increase in bromocriptine exposure is expected to be small.

How serious is the interaction between Bromocriptine and Larotrectinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed. Watch for dopaminergic adverse effects such as nausea or hypotension.

What other medicines interact with Bromocriptine?

MediHelp also lists interactions of Bromocriptine with, for example, Amisulpride, Atazanavir, Cobicistat. The full list is on the Bromocriptine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in